Takeda CHRO reports 71,836 ADS holdings
Takeda Pharmaceutical (TAK) executive Nicola Deidre Petal Greenway, Chief Human Resources Officer, reported initial beneficial ownership of 71,836 American Depositary Shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Takeda Pharmaceutical (TAK) executive Nicola Deidre Petal Greenway, Chief Human Resources Officer, reported initial beneficial ownership of 71,836 American Depositary Shares.
This total includes 37,458 restricted stock units (RSUs), which are scheduled to vest in tranches on July 1, 2026, July 1, 2027, and July 1, 2028.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | American Depositary Shares | -- | -- | -- |
Footnotes (1)
- F1. Includes 37,458 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (18,534 shares), July 1, 2027 (12,880 shares) and July 1, 2028 (6,044 shares).
Key Figures
Key Terms
restricted stock units financial
RSUs financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Takeda (TAK) executive Nicola Greenway report on this Form 3?
How many RSUs does Nicola Greenway hold in Takeda (TAK)?
What is the vesting schedule for Nicola Greenway’s Takeda (TAK) RSUs?
What total Takeda (TAK) stake does Nicola Greenway report after this Form 3?
Are Nicola Greenway’s Takeda (TAK) holdings direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.